Vnitr Lek 2008, 54(10):1010-1013

The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology

P. Kuchynka1, T. Paleček1,*, S. ©imek1, J. C. Lubanda1, M. Elleder2, I. ©pička3, P. Jansa1, A. Linhart1
1 II. interní klinika - klinika kardiologie a angiologie 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Aleą Linhart, DrSc.
2 Ústav dědičných a metabolických poruch 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Milan Elleder, DrSc.
3 I. interní klinika - klinika hematologie 1. lékařské fakulty UK a VFN Praha, přednosta doc. MUDr. Marek Trněný, DrSc.

The authors describe an interesting case of isolated cardiac manifestation of AL-amyloidosis manifesting as an incipient infiltrative cardiomyopathy with heart failure symptoms due to moderate left ventricular diastolic dysfunction. Restrictive cardiomyopathy with severe diastolic dysfunction is considered as the characteristic manifestation of fully developed cardiac amyloidosis. However, the organ deposition of amyloid is progressive and left ventricular filling worsens continuously, starting with less advanced forms of diastolic dysfunction; the restrictive physiology is characteristic only for advanced phases of the disease. Therefore, the possibility of the incipient infiltrative cardiomyopathy due to the amyloidosis should be considered in patients with heart failure symptoms and echocardiographic findings of unexplained left ventricular hypertrophy with only mild or moderate diastolic dysfunction.

Keywords: heart failure; echocardiography; cardiomyopathy; amyloidosis

Received: April 27, 2008; Accepted: June 3, 2008; Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuchynka P, Paleček T, ©imek S, Lubanda JC, Elleder M, ©pička I, et al.. The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology. Vnitr Lek. 2008;54(10):1010-1013.
Download citation

References

  1. Pepys MB. Amyloidosis. Annu Rev Med 2006; 57: 223-241. Go to original source... Go to PubMed...
  2. Adam Z, Sčudla V. Clinical maniofestation of AL-amyloidosis and some other types of amyloidosis. Vnitř Lék 2001; 47: 36-45. Go to PubMed...
  3. Shah BK, Inoue Y, Mehra MR. Amyloidosis and the heart. Arch Intern Med 2006; 166: 1805-1813. Go to original source... Go to PubMed...
  4. Dubrey SW, Cha K, Anderson J et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998; 91: 141-157. Go to original source... Go to PubMed...
  5. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 patients. Semin Hematol 1995; 32: 45-49.
  6. Palka P, Lange A, Donnelly E et al. Doppler tissue echocardiographic features of cardiac amyloidosis. J Am Soc Echocardiogr 2002; 15: 1353-1359. Go to original source... Go to PubMed...
  7. Brychta T, Pařenica J, Zatočil T et al. Restrictive cardiomyopathy as a manifestation of primary amyloidosis. Vnitř Lék 2004; 50: 66-71. Go to PubMed...
  8. Murtagh B, Hammill SC, Gertz MA et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy proven cardiac involvement. Am J Cardiol 2005; 95: 535-537. Go to original source... Go to PubMed...
  9. Klein AL, Hatle LK, Burstow DJ et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1989; 13: 1017-1026. Go to original source... Go to PubMed...
  10. Linhart A, Paleček T, Aschermann M. Echokardiografie pro praxi. Praha: Audioscan 2002: 117-118.
  11. Pellikka PA, Holmes DR, Edwards WD et al. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 1988; 148: 662-666. Go to original source...
  12. Oh JK, Hatle LK, Tajik AJ et al. Diastolic heart failure can be diagnose by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006; 47: 500-506. Go to original source... Go to PubMed...
  13. Elliott P, Anderson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276. Go to original source... Go to PubMed...
  14. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002; 99: 4276-4282. Go to original source... Go to PubMed...
  15. Jaccard A, Moreau P, Leblond V et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 2007; 357: 1083-1093. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.